Serratus and Parasternal Infrapectoral Block for Breast Surgery. A Randomized Controlled Double Blinded Study to Measure Impact on Time to Hospital Discharge in an Outpatient Setting.

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Effective pain control is important following breast surgery as it improves quality of recovery, decreases the risk of chronic pain development and reduction of overall health care cost. Current strategies of pain management for breast surgery include use of opioid medication or addition of regional anesthesia along with general anesthesia. Serratus block and parasternal infrapectoral blocks are newly developed fascial plane blocks that are technically easy to perform, effective and safe based on our daily clinical practice and published evidence. We are comparing the addition of serratus and parasternal infrapectoral nerve block with general anesthesia to a combination of placebo and general anesthesia for breast reduction surgery. We propose that this would result in an improved efficiency resulting in early hospital discharge and improve quality of patient care, following breast reduction surgery.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• women aged 18-80 years

• ASA I to III (American Society of Anesthesiologists Physical Status Classification System)

• Undergoing unilateral oncoplastic breast reduction mammoplasty, simple mastectomy surgery, or lumpectomy at St. Joseph's Hospital.

• Day surgery procedures

Locations
Other Locations
Canada
St. Joseph's Hospital
RECRUITING
London
Contact Information
Primary
Abhijit Biswas, MD
abhijit.biswas@lhsc.on.ca
+14168301696
Time Frame
Start Date: 2019-07-01
Estimated Completion Date: 2025-06
Participants
Target number of participants: 120
Treatments
Active_comparator: Study Group
Ultrasound guided unilateral serratus plane block and unilateral parasternal infrapectoral block with 0.5% ropivacaine.
Sham_comparator: Control Group
Ultrasound guided unilateral serratus plane block and unilateral parasternal infrapectoral block with 0.9% saline.
Related Therapeutic Areas
Sponsors
Leads: Western University, Canada

This content was sourced from clinicaltrials.gov